El premio se realiza en plena ronda de inversión que Laminar ha abierto hasta el 5 de febrero, momento en el que se espera recibir poco después el resultado del análisis intermedio del ensayo clín...
Read more
Su proyecto Fluxus, gracias al uso de Inteligencia Artificial y algoritmos nativos, permite una sesión de trabajo clínica con una interfase huésped-tumor única, proporcionando el tipo y subtipo de...
Read more
The funding is intended to support the growth of our platform, which is now the largest virtual/augmented reality solution supporting both physical and mental health, revolutionizing digital healthcar...
Read more
GENESIS Biomed has acted in some cases as Venture Builder. The spin-off Telara Pharma and the spin-off RetinaReadRisk are two successful examples where GENESIS Biomed has played this role.
Read more
This new incorporation will increase the number of projects in which to invest, consolidating GENESIS Tech Transfer Boost as a relevant player in the private financing of early-stage projects in the e...
Read more
The combined Group, named 3PBIOVIAN, will offer unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substance and Drug Pr...
Read more
Proceeds from the financing will be used to advance the company’s pipeline of wholly-owned, off-the-shelf cell therapies for multiple indications, including its lead investigational candidate, NRTX-...
Read more
The investment will be used to complete three phase II clinical trials in which the efficacy of its most advanced products is being studied, namely PBF-680 in patients with chronic obstructive pulmona...
Read more
Braingaze’s innovative technology leverages proprietary biomarkers of eye micromovements, casual video games and deep learning (AI) algorithms. The diagnostic solutions offer cutting-edge accuracy a...
Read more
Braingaze, the University of Barcelona’s digital cognitive health spin-off, successfully closed a €1.5 million investment round. The funding will accelerate the clinical and business development o...
Read more
Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in...
Read more
Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the development of transformational therapies to improve the lives of patients, today announced the close o...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
